Press release
Lawsuit filed for Investors in shares of Baxter International Inc. (NYSE: BAX)
A lawsuit was filed on behalf of investors in Baxter International Inc. (NYSE: BAX) shares over alleged securities laws violations
Investors who purchased a significant amount of shares of Baxter International Inc. (NYSE: BAX) have certain options and for certain investors are short and strict deadlines running. Deadline: September 11, 2023. NYSE: BAX investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Deerfield, IL based Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. On February 9, 2023, before the market opened, Baxter International Inc. released its fourth quarter and full year 2022 financial results, revealing that the Company did not meet its earning guidance for the year. The Company claimed that "supply chain headwinds continue to weigh on business performance.
Shares of Baxter International Inc. (NYSE: BAX) declined from $62.12 per share on August 19, 2022 to as low as $37.35 per share on March 17, 2023.
According to the complaint the plaintiff alleges on behalf of purchasers of Baxter International Inc. (NYSE: BAX) common shares between May 25, 2022 and February 8, 2023, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between May 25, 2022 and February 8, 2023, the defendants made false statements and/or concealed that: (i) the Company concealed the true extent of the supply chain problems it was experiencing while simultaneously exaggerating its ability to maintain a healthy supply chain in the face of global pressures; (ii) as a result, the Company's projected earnings were materially misleading during the Class Period; (iii) the foregoing, once revealed, was reasonably likely to have a material negative impact on the Company's financial condition; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times
Those who purchased shares of Baxter International Inc. (NYSE: BAX) have certain options and should contact the Shareholders Foundation.
Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lawsuit filed for Investors in shares of Baxter International Inc. (NYSE: BAX) here
News-ID: 3152009 • Views: …
More Releases from Shareholders Foundation
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc..
Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed…
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation.
Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open…
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced.
Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm…
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements.
Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
More Releases for Baxter
Kingdom in the Redwoods - By Keven Baxter
Kharis Publishing announces the release of "Kingdom in the Redwoods," a fast-moving adventure transporting readers to not one, but two, captivating worlds where they'll join the amazing journey of Aaron, Benji, and Hannah as they're tested in ways they never imagined. All new series.
California just sued Chino Valley Unified School District to strike down the district's parental notification policy. The lawsuit filed by the California Attorney General on August 28,…
Sterile IV Containers Market | Angiplast, B. Braun Medical, Baxter, Baxter
The global sterile iv containers market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the sterile iv containers market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Hospital Supplies Market Size, Share, Growth & Forecast to 2026 | Key Players Me …
Hospital Supplies market is valued at USD 37.65 billion in 2019.
Bizlytik analysts forecast the global Hospital Supplies market to grow at a CAGR of 13.4% during the forecast period, according to their latest market research report.
Request a Free Sample Report @ https://bizlytik.com/report/hospital-supplies-market/#request-for-sample
Hospital supplies are products used in providing care, especially in the hospital. These supplies help medical professionals and other medical staff to treat patients and keep their surroundings clean…
Anti Asthma Drugs Market 2018; Leading Players Baxter International, Baxter Inte …
The Global Anti-Asthma Drugs Market has been segmented on the basis of drug class, route of administration, therapy, trigger, type, and lastly, region. On the basis of drug class, this market has been segmented into bronchodilators, corticosteroids, leukotriene antagonists, mast cell stabilizers, monoclonal antibody, and others. Bronchodilators have been further segmented into anticholinergics, beta agonists, and Xanthines.
Based on the route of administration, the market has been segmented into inhaled, intravenous,…
Dysmenorrhea Treatment Market Leading Players Baxter International, Baxter Inter …
Global Dysmenorrhea Treatment Information, By Type Primary, Secondary, By Treatment Non-Steroidal Anti-Inflammatory Drugs, Hormonal, Combined Oral Contraceptive, By End User Hospitals And Clinics, Diagnostic Centers, Pharmaceutical Companies And Others - Forecast To 2023
Dysmenorrhea Treatment Market – Highlights
Pain during menstruation is known as dysmenorrhea. Increase in incidence of dysmenorrhea, which is attributed to changing lifestyle, addiction to smoking and alcohol, hormonal changes and physical and mental stress, favor the growth of…
World Peritoneal Dialysis Solution Market 2017 - Baxter, Fresenius, Nikkiso, Bax …
The report on Global Peritoneal Dialysis Solution Industry 2017 is a professional, in-depth study that includes insights extracted from complex information, which clients can use for their business advantage. A large volume of precise, reliable market data has been distilled into clear and actionable insight for clients so that they can formulate their plans or make crucial business decisions with precision.
Get Free Report Sample @ http://www.fiormarkets.com/report-detail/40468/request-sample
The report begins with an…
